 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Johns Hopkins University Center for Tuberculosis Research |
| Street 1: | 1550 Orleans Street |
| Street 2: | 1M.o8 |
| City: | Baltimore |
| Province: | Maryland |
| Post Code: | 21231-1002 |
| Country: | United States of America |
| Phone: | 14109551755 |
| Email: | rchaiss@jhmi.edu |
| Web Site: | http://tbhiv-create.org |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Technical agencies |
| Organization Type - Primary: | Academic / Research Institution |
| Organization Type - Secondary: | None |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| Academic center for laboratory, clinical and epidemiologic study of tuberculosis and TB control. | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 100 + |
| Number of part-time staff who are directly involved with TB: | 51 - 99 |
| Number of volunteers who are directly involved with TB: | 1 - 5 |
| What is your organization's annual budget (USD) dedicated to TB? | >$10 MIL |
| How did you hear about the Stop TB Partnership: | Other partners |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | United States of America |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| The Center for TB Research is actively involved in the Global Plan at the Partnership level through the TB/HIV Committee, the Working Group on New Drugs and the Working Group on New Diagnostics. The Center is the home of the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE), funded by the Gates Foundation. In the US, the Center provides leadership in research networks including the TB Trials Consortium, the AIDS Clinical Trials Group and the TB Epidemiology Studies Consortium. We are actively involved in TB control efforts in the US, Brazil, South Africa, India, Malawi, Lesotho and other countries. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which WHO region is the main focus of your work: | Global |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Brazil China India Lesotho Malawi Panama South Africa Uganda United States of America Zambia |
Specializations | |
|
Advocacy, communication and social mobilization Delivery of health services and care Research and Development Technical Assistance |
Specializations in Countries | |
| Research and Development | Brazil |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: Technical assistance for DOTS expansion. Drug-Resistant TB: Research on new TB drugs. TB-HIV: Global consortium (CREATE) for studies of TB/HIV control and evidence-based advocacy for strengthening policy. New Diagnostics: Global research on new diagnostics. New TB Drugs: Leadership in clinical trials of new drugs with independent grants and through the TB Trials Consortium and AIDS Clinical Trials Group. Laboratory research on new drugs and regimens in the mouse, guinea pig and rabbit models and basic research on drug development. Fundamental Research: Bench research on TB genomics, pathogenesis and biology. Operational Research: Global studies of implementation science for TB. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | |
| Last updated: | May 9, 2012 |